SQLite Web: event_store.db

Update row 129380 in events

seq

Primary key. INTEGER

id

TEXT NOT NULL

kind

TEXT NOT NULL

ts

TEXT NOT NULL

actor

TEXT

subject_entity_ids

TEXT

payload

{"created_at":"2026-04-18T03:05:05.644967+00:00","dedupe_key":"signal_enriched:discovery_sec_filing_delta:48f52da37ac1208b","evidence_event_ids":["evt_28d05f0a0e69"],"signal_type":"discovery_sec_filing_delta","source":"discovery_sec_filings","value":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1438133/0001438133-26-000040.txt","as_of":"2026-04-18T03:05:05.644967+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1438133/0001438133-26-000040.txt","company":"TANDEM DIABETES CARE INC","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1438133/0001438133-26-000040.txt","article_chars":2313,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_c046c14e84a3ac6e","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1438133/0001438133-26-000040.txt","content_type":"text/plain","enriched_at":"2026-04-18T03:29:40.252097+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1438133/0001438133-26-000040.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1438133/0001438133-26-000040.txt","source_event_id":"evt_28d05f0a0e69","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"4","fp":"ff79a5e01d2ea971","kind":"sec_filing","published_at":"20260417","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.78,"dates_mentioned":["2026-04-17","2026-04-15","2025-07-15","2024-07-15"],"entities":[{"asset_class":"equity","name":"Tandem Diabetes Care Inc","relevance":"high","symbol":"TNDM","type":"issuer"},{"asset_class":"person","name":"Jean-Claude Kyrillos","relevance":"high","symbol":"","type":"reporting_person"},{"asset_class":"plan","name":"Tandem Diabetes Care Inc 2023 Long-Term Incentive Plan (as amended)","relevance":"medium","symbol":"","type":"equity_plan"}],"event_type":"other","information_gaps":["The cleaned text excerpt does not clearly show the exact number of RSUs/shares involved in the reported transaction (the numeric fields appear but are not fully interpretable from the provided excerpt).","The excerpt does not specify the exact transaction code(s) or whether the Form 4 reflects vesting, withholding, or another specific insider activity beyond the narrative provided.","No prior known state is included in the prompt, so the \u201cwhat changed vs prior known state\u201d cannot be determined from the provided information alone."],"key_facts":["SEC filing: Form 4 (SEC conforming submission type 4) for Tandem Diabetes Care Inc (TNDM).","Filed as of date: 2026-04-17; conforming period of report: 2026-04-15.","Reporting owner: Jean-Claude Kyrillos; described as EVP & Chief Operating Officer.","Transaction/award described involves Restricted Stock Units (RSUs) and common stock.","The text states: \u201cShares withheld by Tandem Diabetes Care Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.\u201d","RSUs were \u201cAwarded on July 15, 2024\u201d pursuant to the \u201cTandem Diabetes Care Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan).\u201d","Vesting terms stated: \u201cRSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 7/15/2025, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.\u201d","Signature line: \u201c/s/ Shannon M. Hansen, Attorney-in-Fact for Jean-Claude Kyrillos\u201d dated 2026-04-17."],"numeric_claims":[{"label":"RSU vesting first tranche date","value":"2025-07-15"},{"label":"RSU first tranche percentage","value":"33%"},{"label":"Number of remaining quarterly installments","value":"8"},{"label":"Filing date (filed as of)","value":"2026-04-17"},{"label":"Conformed period of report","value":"2026-04-15"}],"primary_claim":"Form 4 for TNDM filed 2026-04-17 reports that Jean-Claude Kyrillos received/holds RSUs with vesting starting 7/15/2025 and that no shares were sold; shares were withheld to satisfy tax withholding on RSU vesting.","relevance_score":0.45,"sentiment":"neutral","source_quality":"high","summary":"Tandem Diabetes Care, Inc. (TNDM) filed a Form 4 on 2026-04-17 reporting an equity award/transaction by executive Jean-Claude Kyrillos dated for the reporting period 2026-04-15. The filing states no shares were sold and describes restricted stock unit (RSU) vesting and tax withholding shares withheld by the company.","topics":["SEC Form 4","insider transaction","restricted stock units (RSUs)","vesting schedule","tax withholding","no shares sold"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 4 \u00b7 TANDEM DIABETES CARE INC \u00b7 Filed 20260417","ticker":"TNDM","tickers":["TNDM"],"title":"TNDM filed 4","url":"https://www.sec.gov/Archives/edgar/data/1438133/0001438133-26-000040.txt"}}

TEXT NOT NULL

source_ref

TEXT

confidence

REAL (default 0.0

dedupe_key

TEXT

episode_id

TEXT

created_at

TEXT NOT NULL (default strftime('%Y-%m-%dT%H:%M:%fZ','now')

Cancel